Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Natural killer cell-mediated cytotoxicity against tumor cells is a crucial effector process of the innate immune system, wherein NK cells recognize and selectively kill transformed (tumor) cells. This killing occurs primarily through two mechanisms: direct release of cytotoxic granules (containing perforin and granzymes) that induce apoptosis of target cells, and through engagement of death receptor pathways via ligands such as Fas ligand or TRAIL, resulting in programmed cell death of target cells[1][3][4]. NK cells play a central role in tumor immunosurveillance and are a key avenue in immunotherapy strategies, especially in cancer, though the term describes a process rather than a discrete therapeutic target[1][2][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Natural killer cell cytotoxicity (against tumor cell) (NK cell cytotoxicity).